Revisiting the clinical trial history and regulatory mechanisms in Nepal in the context of COVID-19 pandemic

Presence of Nepal in global clinical trials has been visibly negligible despite the history of conducting large scaled randomized controlled trial on Hepatitis E vaccine decades ago. Majority of the problem is attributed to the lack of collaborative work, financial and human resource constrains. COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Paudel, Suman Sharma, Sapkota, Yunima, Gyanwali, Pradip, Dhimal, Meghnath, Ghimire, Namita, Pant, Suman, Bhandari, Dinesh, Mandal, Shrawan Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657897/
https://www.ncbi.nlm.nih.gov/pubmed/36407842
http://dx.doi.org/10.1016/j.conctc.2022.101038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657897/
https://www.ncbi.nlm.nih.gov/pubmed/36407842
http://dx.doi.org/10.1016/j.conctc.2022.101038

Ejemplares similares